BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36989901)

  • 1. The anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeutics.
    Ghosh M; Rana S
    Int Immunopharmacol; 2023 May; 118():110081. PubMed ID: 36989901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In response to complement anaphylatoxin peptides C3a and C5a, human vascular endothelial cells migrate and mediate the activation of B-cells and polarization of T-cells.
    Shivshankar P; Li YD; Mueller-Ortiz SL; Wetsel RA
    FASEB J; 2020 Jun; 34(6):7540-7560. PubMed ID: 32301538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Anaphylatoxin Receptor Expression and C3a/C5a Functions in Anaphylatoxin Receptor Reporter Mice.
    Laumonnier Y; Karsten CM; Köhl G; Köhl J
    Curr Protoc Immunol; 2020 Sep; 130(1):e100. PubMed ID: 32710701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New concepts on the therapeutic control of complement anaphylatoxin receptors.
    Hawksworth OA; Li XX; Coulthard LG; Wolvetang EJ; Woodruff TM
    Mol Immunol; 2017 Sep; 89():36-43. PubMed ID: 28576324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutraligands of C5a can potentially occlude the interaction of C5a with the complement receptors C5aR1 and C5aR2.
    Das A; Ghosh M; Gupta PK; Rana S
    J Cell Biochem; 2023 Feb; 124(2):266-281. PubMed ID: 36565188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaphylatoxins: their role in bacterial infection and inflammation.
    Haas PJ; van Strijp J
    Immunol Res; 2007; 37(3):161-75. PubMed ID: 17873401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaphylatoxin receptor promiscuity for commonly used complement C5a peptide agonists.
    Li XX; Clark RJ; Woodruff TM
    Int Immunopharmacol; 2021 Nov; 100():108074. PubMed ID: 34454293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct roles of the anaphylatoxin receptors C3aR, C5aR1 and C5aR2 in experimental meningococcal infections.
    Muenstermann M; Strobel L; Klos A; Wetsel RA; Woodruff TM; Köhl J; Johswich KO
    Virulence; 2019 Dec; 10(1):677-694. PubMed ID: 31274379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C4a: An Anaphylatoxin in Name Only.
    Barnum SR
    J Innate Immun; 2015; 7(4):333-9. PubMed ID: 25659340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revealing the signaling of complement receptors C3aR and C5aR1 by anaphylatoxins.
    Wang Y; Liu W; Xu Y; He X; Yuan Q; Luo P; Fan W; Zhu J; Zhang X; Cheng X; Jiang Y; Xu HE; Zhuang Y
    Nat Chem Biol; 2023 Nov; 19(11):1351-1360. PubMed ID: 37169960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Complement activation and inflammation].
    Abe M
    Rinsho Byori; 2006 Jul; 54(7):744-56. PubMed ID: 16913666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74).
    Cain SA; Monk PN
    J Biol Chem; 2002 Mar; 277(9):7165-9. PubMed ID: 11773063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational design of antibody-like peptides for targeting the human complement fragment protein C5a.
    Ghosh M; Shadangi S; Rana S
    Proteins; 2024 Apr; 92(4):449-463. PubMed ID: 37933678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of anaphylatoxin C5a on antigen presenting cells, roles for C5aR1 and C5aR2.
    Zaal A; van Ham SM; Ten Brinke A
    Immunol Lett; 2019 May; 209():45-52. PubMed ID: 30959077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C5aR2 receptor: The genomic twin of the flamboyant C5aR1.
    Das A; Gupta PK; Rana S
    J Cell Biochem; 2022 Nov; 123(11):1841-1856. PubMed ID: 35977039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human C3a and C3a desArg anaphylatoxins have conserved structures, in contrast to C5a and C5a desArg.
    Bajic G; Yatime L; Klos A; Andersen GR
    Protein Sci; 2013 Feb; 22(2):204-12. PubMed ID: 23184394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Complement Receptor C5aR2: A Powerful Modulator of Innate and Adaptive Immunity.
    Li XX; Lee JD; Kemper C; Woodruff TM
    J Immunol; 2019 Jun; 202(12):3339-3348. PubMed ID: 31160390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C5aR1 interacts with TLR2 in osteoblasts and stimulates the osteoclast-inducing chemokine CXCL10.
    Mödinger Y; Rapp A; Pazmandi J; Vikman A; Holzmann K; Haffner-Luntzer M; Huber-Lang M; Ignatius A
    J Cell Mol Med; 2018 Dec; 22(12):6002-6014. PubMed ID: 30247799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement C5a Receptor 1 Exacerbates the Pathophysiology of
    Herrmann JB; Muenstermann M; Strobel L; Schubert-Unkmeir A; Woodruff TM; Gray-Owen SD; Klos A; Johswich KO
    mBio; 2018 Jan; 9(1):. PubMed ID: 29362231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells.
    Takabayashi T; Shimizu S; Clark BD; Beinborn M; Burke JF; Gelfand JA
    Surgery; 2004 May; 135(5):544-54. PubMed ID: 15118592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.